📣 Notice: Short Maintenance Tonight (May 19th)
Due to increasing user numbers, we’re upgrading our servers this evening. StocksGuide will be unavailable for about 5–10 minutes between 4:00 PM and 5:00 PM (EDT / New York time). Afterwards, you’ll continue to benefit from fast and stable site performance. Thank you for your understanding! Your StocksGuide Team

$9.67
1.68%
Nasdaq, May 16, 10:00 pm CET
ISIN
US2681582019
Symbol
DVAX
Reports
Quarter | Annual
Index
NASDAQ Composite, S&P SmallCap 600
Sector
Health
Industry
Biotechnology

Dynavax Technologies Corporation Target price 2025 - Analyst rating & recommendation

Dynavax Technologies Corporation Classifications & Recommendation:

Buy
80%
Sell
20%

Dynavax Technologies Corporation Price Target

Target Price $24.53
Price $9.67
Potential
153.62%
register free of charge
Number of Estimates 4
4 Analysts have issued a price target Dynavax Technologies Corporation 2026 . The average Dynavax Technologies Corporation target price is $24.53. This is
153.62%
register free of charge
higher than the current stock price. The highest price target is
$31.00 220.58%
register free of charge
, the lowest is
$11.10 14.79%
register free of charge
.
A rating was issued by 5 analysts: 4 Analysts recommend Dynavax Technologies Corporation to buy, 0 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Dynavax Technologies Corporation stock has an average upside potential 2026 of
153.62%
register free of charge
. Most analysts recommend the Dynavax Technologies Corporation stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 277.25 329.39
19.36% 18.81%
EBITDA Margin 1.42% 5.33%
112.30% 276.02%
Net Margin 8.92% -9.69%
435.12% 208.59%

5 Analysts have issued a sales forecast Dynavax Technologies Corporation 2025 . The average Dynavax Technologies Corporation sales estimate is

$329m
Unlock
. This is
11.80% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$335m 13.77%
Unlock
, the lowest is
$319m 8.38%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $277m 19.36%
2025
$329m 18.81%
Unlock
2026
$384m 16.57%
Unlock
2027
$436m 13.56%
Unlock
2028
$517m 18.47%
Unlock
2029
$555m 7.44%
Unlock

1 Analyst has issued an EBITDA forecast Dynavax Technologies Corporation 2025 . The average Dynavax Technologies Corporation EBITDA estimate is

$17.5m
Unlock
. This is
1,889.80% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$17.5m 1,889.80%
Unlock
, the lowest is
$17.5m 1,889.80%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $3.9m 114.68%
2025
$17.5m 346.31%
Unlock
2026
$34.0m 93.64%
Unlock
2027
$44.5m 30.92%
Unlock

EBITDA Margin

2024 1.42% 112.30%
2025
5.33% 276.02%
Unlock
2026
8.85% 66.04%
Unlock
2027
10.20% 15.25%
Unlock

5 Dynavax Technologies Corporation Analysts have issued a net profit forecast 2025. The average Dynavax Technologies Corporation net profit estimate is

$-31.9m
Unlock
. This is
51.33% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$43.3m 166.05%
Unlock
, the lowest is
$-69.3m 5.66%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $24.7m 500.00%
2025
$-31.9m 228.98%
Unlock
2026
$66.1m 307.02%
Unlock
2027
$90.0m 36.22%
Unlock
2028
$126m 39.53%
Unlock
2029
$130m 3.45%
Unlock

Net Margin

2024 8.92% 435.12%
2025
-9.69% 208.59%
Unlock
2026
17.20% 277.50%
Unlock
2027
20.64% 20.00%
Unlock
2028
24.31% 17.78%
Unlock
2029
23.40% 3.74%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.20 -0.26
500.00% 230.00%
P/E negative
EV/Sales 2.40

5 Analysts have issued a Dynavax Technologies Corporation forecast for earnings per share. The average Dynavax Technologies Corporation EPS is

$-0.26
Unlock
. This is
50.94% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.35 166.04%
Unlock
, the lowest is
$-0.56 5.66%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.20 500.00%
2025
$-0.26 230.00%
Unlock
2026
$0.53 303.85%
Unlock
2027
$0.73 37.74%
Unlock
2028
$1.02 39.73%
Unlock
2029
$1.05 2.94%
Unlock

P/E ratio

Current -18.32 109.22%
2025
-37.48 104.59%
Unlock
2026
18.11 148.32%
Unlock
2027
13.29 26.62%
Unlock
2028
9.53 28.29%
Unlock
2029
9.21 3.36%
Unlock

Based on analysts' sales estimates for 2025, the Dynavax Technologies Corporation stock is valued at an EV/Sales of

2.40
Unlock
and an P/S ratio of
3.53
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.68 32.32%
2025
2.40 10.51%
Unlock
2026
2.06 14.21%
Unlock
2027
1.81 11.94%
Unlock
2028
1.53 15.59%
Unlock
2029
1.42 6.93%
Unlock

P/S ratio

Current 3.94 33.59%
2025
3.53 10.55%
Unlock
2026
3.02 14.21%
Unlock
2027
2.66 11.94%
Unlock
2028
2.25 15.59%
Unlock
2029
2.09 6.93%
Unlock

Current Dynavax Technologies Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JMP Securities
Locked
➜
Locked
 Locked May 07 2025
Goldman Sachs
Locked
➜
Locked
 Locked Apr 17 2025
Citizens Capital Markets
Locked
➜
Locked
 Locked Feb 21 2025
HC Wainwright & Co.
Locked
➜
Locked
 Locked Feb 21 2025
Goldman Sachs
Locked
➜
Locked
 Locked Feb 11 2025
HC Wainwright & Co.
Locked
➜
Locked
 Locked Jan 14 2025
HC Wainwright & Co.
Locked
➜
Locked
 Locked Nov 08 2024
Analyst Rating Date
Locked
JMP Securities:
Locked
➜
Locked
 May 07 2025
Locked
Goldman Sachs:
Locked
➜
Locked
 Apr 17 2025
Locked
Citizens Capital Markets:
Locked
➜
Locked
 Feb 21 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
 Feb 21 2025
Locked
Goldman Sachs:
Locked
➜
Locked
 Feb 11 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
 Jan 14 2025
Locked
HC Wainwright & Co.:
Locked
➜
Locked
 Nov 08 2024

Discover more stocks with a high price target

TUI 57.08%
Novo Nordisk 53.62%
BioNTech SE - ADR 44.95%
MongoDB 36.70%
NIO ADR 30.19%
Alibaba Group Holding Ltd 28.29%
Pfizer 23.80%
Tencent Holdings Ltd. 22.89%
Alphabet 19.17%
Infineon 18.68%
NVIDIA 18.58%
Adidas 18.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today